跳至主要内容
临床试验/CTRI/2025/03/083591
CTRI/2025/03/083591尚未招募Phase 3 4

An Open-Labelled Three-Armed Randomized Controlled Clinical Trial To Evaluate The Effect Of Sub-Lingual Brahmi (Bacopa Monnieri) Drops In The Management Of Abdominal Colic

Dr Kajal Patel1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月15日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Decrease in Pain, Decrease in VAS Pain Score, Decrease in intensity and duration of pain, Decrease in following criteria of coliky pain

研究概览

简要总结

The primary objective of this study is to evaluate and compare the efficacy of Brahmi extract in two forms sublingual drops and capsulesagainst a conventional pharmaceutical treatment comprising Mefenamic Acid and Dicyclomine Hydrochloride for the management of abdominal colic. The secondary objective is to preparation of brahmi drops and brahmi capsule. Analytical study of drops and capsule.The trial follows an open-labelled, three-armed, randomized controlled design with a sample size of 60 patients, divided into three groups of 20 each. The study spans 10 days, including a 3-day treatment period and a 7-day follow-up. Participants will be assessed based on subjective criteria such as pain intensity, duration, and location, as well as objective criteria like tenderness, nausea, vomiting, diarrhea, fatigue, and fainting, using standardized assessment scales.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Participants aged between 18 and 60 years.
  • Patients presenting with abdominal colicky pain that does not require immediate surgical intervention.
  • Patients diagnosed with the following conditions, where Brahmi (Bacopa monnieri) drops may be beneficial: i.
  • Multiple urinary calculi (unilateral or bilateral) without accompanying hydronephrosis.
  • Cholecystitis and cholelithiasis without severe complications.
  • Abdominal cramps and biliary colic.
  • Dysmenorrhea (painful menstruation).
  • Appendicitis not necessitating immediate surgical intervention.
  • Patients of all genders, regardless of caste, religion, and socio-economic status.

排除标准

  • Patients with renal or ureteric calculi that are accompanied by severe hydronephrosis, which requires immediate or urgent intervention.
  • Individuals with obstructive renal calculi leading to severe infections, such as pyelonephritis, that necessitate immediate medical treatment.
  • Patients diagnosed with obstructive jaundice, a condition requiring urgent management due to bile duct obstruction, often caused by gallstones or tumors.
  • Any patient with a condition requiring immediate surgical intervention, such as:
  • Complete bowel obstruction.
  • Perforated appendix.
  • Any other acute abdominal condition that mandates urgent surgery.
  • Patients with severe systemic conditions, such as uncontrolled diabetes or cardiovascular disease, that may complicate the management of abdominal colic or interfere with the study outcomes.
  • Pregnant or breastfeeding women, due to potential risks and lack of sufficient safety data on the use of Brahmi (Bacopa monnieri) drops in these populations.
  • Patients Who are not willing to give consent.

结局指标

主要结局

Decrease in Pain, Decrease in VAS Pain Score, Decrease in intensity and duration of pain, Decrease in following criteria of coliky pain

时间窗: Intervention will be done for 3 day, assessment will be done on 3rd day + follow up will be done on 7th day.

1. Tenderness

时间窗: Intervention will be done for 3 day, assessment will be done on 3rd day + follow up will be done on 7th day.

2. Nausea

时间窗: Intervention will be done for 3 day, assessment will be done on 3rd day + follow up will be done on 7th day.

3. Vomiting

时间窗: Intervention will be done for 3 day, assessment will be done on 3rd day + follow up will be done on 7th day.

4. Diarrhoea

时间窗: Intervention will be done for 3 day, assessment will be done on 3rd day + follow up will be done on 7th day.

5. Fatigue

时间窗: Intervention will be done for 3 day, assessment will be done on 3rd day + follow up will be done on 7th day.

6. Fainting

时间窗: Intervention will be done for 3 day, assessment will be done on 3rd day + follow up will be done on 7th day.

次要结局

  • Improve overall quality of life(3 DAYS)

研究者

发起方
Dr Kajal Patel
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Kajal Patel

Parul Institute of Ayurved

研究点 (1)

Loading locations...

相似试验

A Three-Group study to know the Effect of Sublingual... | 临床试验